BALTIMORE, MD, Feb. 15, 2018 -- Medical Therapeutics, a wholly owned subsidiary of View Systems, Inc. (OTC Pink: VSYM), today announced that it has hired additional professionals to staff its new medical division, Medical Therapeutics, a concierge medical service providing sexual health therapies with FDA approved medicines. These markets are projected to reach $7.64 billion in 2019.
Martin Maassen, MD, Medical Director of Medical Therapeutics, states, "We have hired three additional staff members including: a seasoned professional from the industry, Mr. William Kelley as Managing Director. Mr. Kelley has stellar credentials; he served as an Army Ranger, retired as a State Trooper in Pennsylvania and was trained in the industry by Dr. S. Dianzumba, Cardiologist and Dr. M. Trombly, Urologist. Mr. Kelley also has been trained through the Board of Urology and has successfully managed multiple clinics."
We will also aggressively open additional clinics in 2018. The demographics of the industry indicate there are over 50 million men over the age of fifty who are experiencing age and health related hormonal difficulties. A variety of maladies such as diabetes, high blood pressure, prostate difficulties, side effects of prescription drugs, testosterone decline and cardiovascular issues make intimacy even more difficult.
About View Systems/Medical Therapeutics:
View Systems, Inc. is entering new and additional markets to include boutique medical clinics offering a variety of specialized procedures to appropriate patient demographics.
Safe Harbor Statement: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
CONTACT: Medical Therapeutics www.maletherapeutics.com 410-449-3200


ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
How Marco Pharma International Preserves German Homeopathic Traditions in America
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 



